Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a CDMO specialized in CART Cells manufacturing, and was part of the Novartis Group. Before, he was Quality Control Head at THERAVECTYS, a company based on lentiviral technology to develop vaccines. Previous to the above, he was Project manager for medical devices in the genetic diagnosis field.

As Head of Operations of PathoQuest site based in Paris, he will further support the growth and advance of NGS-based solutions for the biosafety of biologics.

Dr. Deplaine is graduated from the University of Pierre et Marie CURIE/Pasteur Institute and holds a Ph.D. in Molecular & Cell Biology. He is co-author of several publications and patents.